Dear CID expert, you have met all Team members today in valuable 90 min. to exchange on DSO & other topics of expertise with the chance to clarify open questions. We are ONE Team and have the same spirit like our peers in the Bayer 04 Leverkusen soccer team. Stay tuned & let's connect! ___ Image created by Stefankai with Midjourney AI and Canva Bayer POAP Term&Conditions: https://bayer.com/poap More info on business use of POAPS at https://go/poap Explore Bayer POAP Collection at https://collections.poap.xyz/bayer

Dear Team, A huge thank you to everyone who joined our recent Global DT&IT Pharma Townhall. Your participation not only made it a success, it also added to the beauty of this time of the year when the snowflakes fall and the air transmits the smell of muled wine and fresh bakery. Reflecting on our team's achievements and exploring Dynamic Shared Ownership (DSO) was insightful, thanks to your active engagement. The shared pictures highlighted our milestones beautifully. Your contributions in discussions and ideas truly enriched the event. Your dedication and support are immensely valued. Let's continue fostering collaboration and empowerment in our work. Thanks again for being a part of this success! Best regards, Patrick Text's draft modified by Open AI's ChatGPT Art inspired by Open AI's Dall-E

During this meeting, we will talk about License Demand Management, our Radiology IT Platform Strategy, the current Solution Design Process, and other topics like new Innovation tools and the upcoming Deep Racer event. Art by Stable Diffusion.

I’ve met Jesus during June 2023. Jesus works at Bayer Pharmaceuticals currently as the Head of Business Disruption. Love Stranger Things, AcceleRed, TeamRed, Science4Berlin, STEM4Health, Hackathons, Biotech, Digital Health, Startups, Web3, Networking For Health, Science, Technology, Pharma, Exobiology, Space, Science Fiction, Germany, Cuba, you can connect with Jesus in LinkedIn: https://www.linkedin.com/in/yeysus/ Twitter: https://twitter.com/yeysus Web3: yeysus.eth/.tez/.near POAPs collections in Welook.io: Bayer: https://welook.io/0x74839F2fF3bb6F98E5f120329A76A89f52b95DCC/poap/c/1 Bayer Haemophilia: https://welook.io/0x74839F2fF3bb6F98E5f120329A76A89f52b95DCC/poap/c/24 Bayer R&D DS&AI: https://welook.io/0x74839F2fF3bb6F98E5f120329A76A89f52b95DCC/poap/c/25 Bayer R&D DS&AI Posters Madrid: https://welook.io/0x74839F2fF3bb6F98E5f120329A76A89f52b95DCC/poap/c/26 Bayer Hellas / Greece: https://welook.io/0x74839F2fF3bb6F98E5f120329A76A89f52b95DCC/poap/c/27 Bayer Product Supply: https://welook.io/0x74839F2fF3bb6F98E5f120329A76A89f52b95DCC/poap/c/28 Bayer Berlin: https://welook.io/0x74839F2fF3bb6F98E5f120329A76A89f52b95DCC/poap/c/29 Bayer IT: https://welook.io/0x74839F2fF3bb6F98E5f120329A76A89f52b95DCC/poap/c/30 Bayer R&D: https://welook.io/0x74839F2fF3bb6F98E5f120329A76A89f52b95DCC/poap/c/31 Bayer Communities: https://welook.io/0x74839F2fF3bb6F98E5f120329A76A89f52b95DCC/poap/c/32 Bayer Medical Affairs: https://welook.io/0x74839F2fF3bb6F98E5f120329A76A89f52b95DCC/poap/c/33